{
    "id": 28808,
    "fullName": "JAK2 R938Q",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "JAK2 R938Q lies within the protein kinase domain 2 of the Jak2 protein (UniProt.org). R938Q confers a gain of function to the Jak2 protein, as demonstrated by constitutive Stat5 signaling (PMID: 29025600), transformation of cultured cells (PMID: 24398328), and also displays resistance to Jak1/2 ATP-competitive inhibitors (PMID: 29025600).",
            "references": [
                {
                    "id": 3844,
                    "pubMedId": 24398328,
                    "title": "Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24398328"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12520,
                    "pubMedId": 29025600,
                    "title": "A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29025600"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3717,
        "geneSymbol": "JAK2",
        "terms": [
            "JAK2",
            "JTK10",
            "THCYT3"
        ]
    },
    "variant": "R938Q",
    "createDate": "10/09/2018",
    "updateDate": "10/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 177519,
        "transcript": "NM_004972",
        "gDna": "chr9:g.5090497G>A",
        "cDna": "c.2813G>A",
        "protein": "p.R938Q",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15037,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, bone marrow mononuclear cells from a pediatric B-cell acute lymphoblastic leukemia with an acquired Jak2 R938Q mutation were resistant to Jakafi (ruxolitinib) (PMID: 29025600).",
            "molecularProfile": {
                "id": 30692,
                "profileName": "JAK2 R938Q"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 80146,
                "name": "childhood B-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 12520,
                    "pubMedId": 29025600,
                    "title": "A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29025600"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30692,
            "profileName": "JAK2 R938Q",
            "profileTreatmentApproaches": [
                {
                    "id": 19065,
                    "name": "JAK2 Inhibitor",
                    "profileName": "JAK2 R938Q"
                },
                {
                    "id": 19066,
                    "name": "JAK Inhibitor (Pan) - ATP competitive",
                    "profileName": "JAK2 R938Q"
                },
                {
                    "id": 19067,
                    "name": "JAK Inhibitor (Pan)",
                    "profileName": "JAK2 R938Q"
                },
                {
                    "id": 19064,
                    "name": "JAK2 Inhibitor - ATP competitive",
                    "profileName": "JAK2 R938Q"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177520,
            "transcript": "NM_001322204",
            "gDna": "chr9:g.5126414_5126415delAGinsCA",
            "cDna": "c.2812_2813delAGinsCA",
            "protein": "p.R938Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177517,
            "transcript": "NM_001322195",
            "gDna": "chr9:g.5090497G>A",
            "cDna": "c.2813G>A",
            "protein": "p.R938Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177518,
            "transcript": "NM_001322196",
            "gDna": "chr9:g.5090497G>A",
            "cDna": "c.2813G>A",
            "protein": "p.R938Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177516,
            "transcript": "NM_001322194",
            "gDna": "chr9:g.5090497G>A",
            "cDna": "c.2813G>A",
            "protein": "p.R938Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 177519,
            "transcript": "NM_004972",
            "gDna": "chr9:g.5090497G>A",
            "cDna": "c.2813G>A",
            "protein": "p.R938Q",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}